Takeda Pharmaceutical Company Limited Key Management Personnel Compensation Postemployment Benefits
Takeda Pharmaceutical Company Limited (TKPHF) reported Key Management Personnel Compensation Postemployment Benefits of JPY 147.00 million for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits · last filed 2025-06-25
| Period end | Key Management Personnel Compensation Postemployment Benefits 12 month |
|---|---|
| 2025-03-31 | 147.00M JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 85.00M JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 43.00M JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 38.00M JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 42.00M JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 45.00M JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 73.00M JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 26.00M JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 38.00M JPY 20-F · filed 2019-06-27 |